Feature|Articles|June 14, 2024
- Pharmaceutical Executive: June 2024
- Volume 44
- Issue 6
Pharmaceutical Executive: June 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Beyond the Numbers: Extrapolating Today’s Trends Forwardalmost 2 years ago
Opposite Spectrumsalmost 2 years ago
2024 Pharm Exec Top 50 Companiesalmost 2 years ago
Craig Tooman: Silencing the Distractionsalmost 2 years ago
Regaining Trust in the Pharma Industryalmost 2 years ago
Succession Attack Plan: Get Strategic with Your Critical Rolesalmost 2 years ago
The Healthcare System is Changing—So How Should We Respond?almost 2 years ago
Biotech Performance Remains Tethered to Rate Expectationsalmost 2 years ago
Pharm Exec Exclusive: Mark Cuban Talks Drug PricingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
What Unexpected Costs do GLP-1 Patients Face?
4
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
5

